{"id":"W2899466366","doi":"10.1007/s40273-018-0732-4","title":"Cost Effectiveness of Midostaurin in the Treatment of Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in the United States","year":2018,"lang":"en","type":"article","venue":"PharmacoEconomics","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":14,"is_retracted":false,"has_abstract":false,"ca_institutions":"Group for Research in Decision Analysis","funders":"Novartis Pharmaceuticals Corporation","keywords":"Midostaurin; Medicine; Cytarabine; Daunorubicin; Quality-adjusted life year; Internal medicine; Myeloid leukemia; Placebo; Oncology; Cost effectiveness; Leukemia; Surgery; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000723917,0.0001969819,0.0004651871,0.0004993934,0.0001546309,0.0006842926,0.0002668791,0.0005822401,0.00155585],"category_scores_gemma":[0.003455998,0.0001047837,0.001293004,0.0007065099,0.000238599,0.0004343553,0.0004030902,0.0006338016,0.00005967397],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003958683,"about_ca_system_score_gemma":0.002055205,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.03000334,"about_ca_topic_score_gemma":0.04726689,"domain_scores_codex":[0.9989736,0.0005989789,0.00008202407,0.00006111537,0.0001494853,0.0001348351],"domain_scores_gemma":[0.9988713,0.0004525258,0.0003368105,0.00001590453,0.00006539995,0.0002580266],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"simulation_or_modeling","study_design_scores_codex":[0.05987322,0.002830846,0.4664372,0.001619318,0.005678637,0.001309308,0.0001710237,0.06191989,0.002479479,0.005805751,0.02039602,0.3714793],"study_design_scores_gemma":[0.006381137,0.009389083,0.9186727,0.0006643694,0.005932397,0.00127925,0.0008140924,0.04408213,0.00117723,0.002303496,0.009220096,0.0000839436],"study_design_candidate":"simulation_or_modeling","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9657511,0.01987479,0.000265513,0.006898975,0.0001337699,0.00005805106,0.002186379,0.00002342198,0.004807998],"genre_scores_gemma":[0.9966144,0.00205639,0.00009271508,0.0005194404,0.00005044597,0.00001155146,0.0004249618,0.000001857756,0.000228181],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03000334,"threshold_uncertainty_score":0.05965739,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.04306016700287379,"score_gpt":0.3720493581454838,"score_spread":0.32898919114261,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}